Detalles de la búsqueda
1.
Vaginal oxygen plus hyaluronic acid on genito-urinary symptoms of breast cancer survivors.
Climacteric
; 26(2): 129-134, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36697389
2.
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study.
Ann Oncol
; 33(5): 534-543, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35182721
3.
Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis.
Hum Reprod
; 37(5): 954-968, 2022 05 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35220429
4.
Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study.
Ann Oncol
; 32(12): 1571-1581, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34656740
5.
Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up.
Ann Oncol
; 35(2): 159-182, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38101773
6.
Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis.
Ann Oncol
; 29(7): 1497-1508, 2018 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29873695
7.
Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the end of the debate.
Ann Oncol
; 33(3): 347-349, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34861375
8.
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in Italy.
Ann Oncol
; 27(12): 2224-2229, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27789469
9.
Ovarian suppression using luteinizing hormone-releasing hormone agonists during chemotherapy to preserve ovarian function and fertility of breast cancer patients: a meta-analysis of randomized studies.
Ann Oncol
; 26(12): 2408-19, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26347105
10.
Body mass index and circulating oestrone sulphate in women treated with adjuvant letrozole.
Br J Cancer
; 110(5): 1133-8, 2014 Mar 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-24448359
11.
Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.
Breast Cancer Res Treat
; 137(1): 167-74, 2013 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23129173
12.
Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysis.
ESMO Open
; 8(6): 102198, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100933
13.
Prognostic value of HER2-low status in breast cancer: a systematic review and meta-analysis.
ESMO Open
; 8(4): 101592, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37413762
14.
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literature.
ESMO Open
; 8(1): 100791, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791639
15.
Optimizing choices and sequences in the diagnostic-therapeutic landscape of advanced triple-negative breast cancer: An Italian consensus paper and critical review.
Cancer Treat Rev
; 114: 102511, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36638600
16.
Confirmatory validation analysis of the PROFFIT questionnaire to assess financial toxicity in cancer patients.
ESMO Open
; 8(6): 102192, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38052104
17.
Safety of pregnancy after breast cancer in young women with hormone receptor-positive disease: a systematic review and meta-analysis.
ESMO Open
; 8(6): 102031, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37879234
18.
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study Group.
ESMO Open
; 8(1): 100747, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36563519
19.
Gonadotropin-releasing hormone analogs for ovarian function protection during chemotherapy in young early breast cancer patients: the last piece of the puzzle?
Ann Oncol
; 28(8): 1683-1685, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28838207
20.
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic review.
ESMO Open
; 7(6): 100629, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36399953